Latest News Releases From The Newsroom
AspyreRx's Approval Boosts Better Therapeutics; Financial Figures, Outlook Drive WD-40, E2open
July 11th, 2023
Shares of Better Therapeutics, Inc. (Nasdaq: BTTX) surged over 20% in after-hours trading as the company received authorization from the FDA for its groundbreaking prescription-only digital therapeutic, AspyreRx. This innovative treatment offers cogn. Read more
CalAmp Posts Loss, Eyes Strategic Options; PriceSmart Posts Mixed Financial Figures
July 10th, 2023
CalAmp Corp. (Nasdaq: CAMP) faced a first-quarter fiscal 2024 loss of $0.11 per share, falling short of the consensus earnings per share estimate of $0.04. Looking ahead, the company expects Q2 FY24 revenues to range between $67 million and $73 mi. Read more
Market Surges: Mobilicom and Novavax See Dramatic Upswing
July 10th, 2023
Shares of Mobilicom Limited (Nasdaq: MOB) climbed over 100% in early trade following the company's announcement of a significant commercial-scale purchase order from Teledyne-FLIR, one of its Tier-1 customers. The purchase order from Teledyne Tech. Read more
Market Turmoil: FMC Slumps on Lowered Revenue Outlook
July 10th, 2023
Shares of FMC Corporation (NYSE: FMC) plummeted over 6% following the release of an update on its second quarter and full-year 2023 outlook. The company now expects second-quarter revenue to be in the range of $1.00 billion to $1.03 billion, signific. Read more
Helen of Troy Beats Estimates; Analysts Take Note of CAVA Group
July 10th, 2023
Helen of Troy Limited (Nasdaq: HELE) reported first-quarter fiscal 2024 adjusted earnings per share (EPS) of $1.94, surpassing the consensus estimate of $1.60. Looking ahead, for the full-year fiscal 2024, the company expects adjusted EPS to fall . Read more
Q2: NanoString and ASE Technology Unveil Financial Figures
July 10th, 2023
NanoString Technologies, Inc. (Nasdaq: NSTG) has reported strong preliminary financial figures for the second quarter of 2023. The company expects Q2 revenue to surpass $44 million, reflecting a remarkable year-on-year growth of approximately 37%. Th. Read more
Nanobiotix Skyrockets On Multi-Million Dollar NBTXR3 Deal
July 10th, 2023
Shares of Nanobiotix S.A. (Nasdaq: NBTX) surged over 50% in pre-market trading following the announcement of a global licensing and commercialization agreement with Janssen Pharmaceutica NV, a subsidiary of Johnson & Johnson (NYSE: JNJ). The agree. Read more
Earnings Preview: MillerKnoll, AngioDynamics, and Theratechnologies
July 09th, 2023
On Wednesday, July 12, several companies are expected to report their financial results, including: MillerKnoll, Inc. (Nasdaq: MLKN), a consumer goods company, is set to release its financial results for the fourth quarter and full-year fiscal 202. Read more
Helen of Troy, WD-40, E2open, CalAmp, and VOXX Set to Release Earnings: A Preview
July 09th, 2023
Several companies are expected to report their financial results on Monday, July 10, including: Helen of Troy Limited (Nasdaq: HELE), a company operating in the consumer products industry, is set to release its first-quarter fiscal 2024 results be. Read more
SEC Charges Former Army Financial Counselor Who Defrauded Gold Star Family Members
July 07th, 2023
FOR IMMEDIATE RELEASE 2023-127 Washington D.C. / CRWE PRESS RELEASE / July 7, 2023 - The Securities and Exchange Commission today charged former U.S. Army financial counselor Caz L. Craffy for defrauding Gold Star family members and others b. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
Micron Technology, Jabil, and Birkenstock Earnings Preview: What to Expect
December 15th, 2024Upcoming Earnings: Synopsys, AeroVironment, and nCino in Focus
December 01st, 2024Countdown to Earnings: Salesforce, Marvell Technology, and Okta Take the Stage
December 01st, 2024Fluence Energy, Agilent Technologies, and Woodward Earnings On Deck: A Preview
November 24th, 2024Earnings Preview: Walt Disney, Applied Materials, and Celcuity Take Center Stage
November 11th, 2024
Member Login